|Project Title||Use of Valsartan, Angiotensin II Receptor Blockers (ARB), and Angiotensin-Converting Enzyme (ACE) Inhibitors|
Wednesday, June 5, 2019
This analysis estimates the rates of valsartan (contaminated and uncontaminated with N-nitrosodimethylamine (NDMA) or N-nitrosodiethylamine (NDEA)), angiotensin II receptor blocker (ARB), and angiotensin-converting enzyme (ACE) inhibitor use in the Sentinel Distributed Database (SDD). Data from January 1, 2000 to June 30, 2018 from 17 Data Partners contributing to the SDD were included in this report. This request was distributed on October 30, 2018.
angiotensin II receptor blocker (ARB)
angiotensin-converting enzyme (ACE) inhibitor
|Population / Cohort|
January 1, 2000 - June 30, 2018
Sentinel Distributed Database (SDD)